Skip to main content
SpringerLink
Log in

Metabolische Enzephalopathien

  • Living reference work entry
  • First Online:
Book cover Klinische Neurologie

Part of the book series: Springer Reference Medizin ((SRM))

  • 388 Accesses

Zusammenfassung

Metabolische Enzephalopathien stellen oft eine diagnostische Herausforderung dar, da sie sich klinisch sehr variabel präsentieren, und – außer im Falle einer schweren Hypo- oder Hyperglykämie – regelhaft andere mögliche Ursachen der neurologischen Symptomatik ausgeschlossen werden müssen, bevor die Diagnose gestellt werden kann. Gerade in Zeiten zunehmender Spezialisierung schärfen sie den Blick für das Ganze und erinnern daran, dass der Mensch mehr ist als die Summe seiner Organe. Sie zeigen auch, dass gute Medizin eine gute Kommunikation zwischen den Disziplinen voraussetzt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Literatur

  • Amodio P, Gatta A (2005) Neurophysiological investigation of hepatic encephalopathy. Metab Brain Dis 20(4):369–379

    Article  PubMed  Google Scholar 

  • Andermann E, Andermann F, Carpenter S, Wolfe LS, Nelson R, Patry G, Boileau J (1986) Action myoclonus-renal failure syndrome: a previously unrecognized neurological disorder unmasked by advances in nephrology. Adv Neurol 43:87–103

    CAS  PubMed  Google Scholar 

  • Atterbury CE, Maddrey W, Conn HO (1978) Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial. Am J Dig Dis 23:398–406

    Article  CAS  PubMed  Google Scholar 

  • Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, Sigal S et al (2010) Rifaximin treatment in hepatic encephalopathy. N Engl J Med 362(12):1071–1081

    Article  CAS  PubMed  Google Scholar 

  • Ben-Ami H, Nagachandran P, Mendelson A, Edoute Y (1999) Drug-induced hypoglycemic coma in 102 diabetic patients. Arch Intern Med 159(3):281–284

    Article  CAS  PubMed  Google Scholar 

  • Bergui M, Bradac GB, Zhong JJ, Barbero PA, Durelli L (2001) Diffusion-weighted MR in reversible Wernicke encephalopathy. Neuroradiology 43:969–972

    Article  CAS  PubMed  Google Scholar 

  • Bernal W. Acute Liver Failure: Review and Update. Int Anaesthesiol Clin 2017 Spring: 55 (2): 92–106.

    Google Scholar 

  • Bernal W, Hyyrylainen A, Gera A et al (2013) Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol 59:74–80

    Article  PubMed  Google Scholar 

  • Bhatia V, Batra Y, Acharya SK (2004) Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure – a controlled clinical trial. J Hepatol 41:89–96

    Article  CAS  PubMed  Google Scholar 

  • Bhatia V, Singh R, Acharya SK (2006) Predictive value of arterial ammonia for complications and outcome in acute liver failure. Gut 55(1):98–104

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brouns R, De Deyn PP (2004) Neurological complications in renal failure: a review. Clin Neurol Neurosurg 107:1–16

    Article  CAS  PubMed  Google Scholar 

  • Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, Rodes J (1999) Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 30:890–895

    Article  CAS  PubMed  Google Scholar 

  • Cardoso FS, Marcelino P, Bagulho L, Karvellas CJ (2017) Acute liver failure: an up-to-date approach. J Crit Care 39:25–30

    Article  PubMed  Google Scholar 

  • Chu K, Kang DW, Kim HJ, Lee YS, Park SH (2002) Diffusion-weighted imaging abnormalities in Wernicke encephalopathy: reversible cytotoxic edema? Arch Neurol 59(1):123–127

    Article  PubMed  Google Scholar 

  • Davies MG, Rowan MJ, Feely J (1991) EEG and event-related potentials in hepatic encephalopathy. Metab Brain Dis 6(4):175–186

    Article  CAS  PubMed  Google Scholar 

  • Deutsche Diabetes Gesellschaft: S3-Leitlinie Therapie des Typ-1-Diabetes – Version 1.0 (2011)

    Google Scholar 

  • Diabetes Control and Complications Trial Research Group (1997) Hypoglycemia in the diabetes control and complications trial. Diabetes 46(2):271–286

    Article  Google Scholar 

  • Elias MF, Elias PK, Seliger SL, Narsipur SS, Dore GA, Robbins MA (2009) Chronic kidney disease, creatinine and cognitive functioning. Nephrol Dial Transplant 24(8):2446–2452

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ellis AJ, Wendon JA, Williams R (2000) Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial. Hepatology 32:536–541

    Article  CAS  PubMed  Google Scholar 

  • Evers S, Tepel M, Obladen M, Suhr B, Husstedt I-W, Grotemeyer KH, Zidek W (1998) Influence of end stage renal failure and hemodialysis on event-related potentials. J Clin Neurophysiol 15(1):58–63

    Article  CAS  PubMed  Google Scholar 

  • Ferenci P, Lockwood AH, Mullen K, Tarter R, Weissenborn K, Blei AT (2002) Hepatic encephalopathy – definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congress of Gastroenterology, Vienna 1998. Hepatology 35(3):716–721

    Article  PubMed  Google Scholar 

  • Ferrara J, Jankovic J (2009) Acquired hepatocerebral degeneration. J Neurol 256(3):320–332

    Article  PubMed  Google Scholar 

  • Gluud LL, Dam G, Les I, Córdoba J, Marchesini G, Borre M, Aagaard NK, Vilstrup H (2015) Branched-chain amino acids for people with hepatic encephalopathy. Cochrane Database Syst Rev (9):CD001939. doi: 10.1002/14651858.CD001939.pub3

  • Gluud LL, Vilstrup H, Morgan MY (2016) Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database Syst Rev (5):CD003044. doi: 10.1002/14651858.CD003044.pub4

  • Hartmann IJC, Groeneweg M, Quero JC et al (2000) The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol 95:2029–2034

    Article  CAS  PubMed  Google Scholar 

  • Hui AY, Chan HL, Leung NW, Hung LC, Chan FK, Sung JJ (2002) Survival and prognostic indicators in patients with hepatitis B virus-related cirrhosis after onset of hepatic decompensation. J Clin Gastroenterol 34(5):569–572

    Article  PubMed  Google Scholar 

  • Ihara M, Ito T, Yanagihara C, Nishimura Y (1999) Wernicke’s encephalopathy associated with hemodialysis: report of two cases and review of the literature. Clin Neurol Neurosurg 101:118–121

    Article  CAS  PubMed  Google Scholar 

  • Jalan R, Olde Damink SW, Deutz NE, Hayes PC, Lee A (2004) Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. Gastroenterology 127:1338–1346

    Article  CAS  PubMed  Google Scholar 

  • Jones EA, Weissenborn K (1997) Neurology and the liver. J Neurol Neurosurg Psychiatry 63(3):279–293

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kandiah N, Tan K, Lim CCT, Venketasubramanian N (2009) Hyperglycemic choreoathetosis. Mov Disord 24(6):915–936

    Article  PubMed  Google Scholar 

  • Karvellas CJ, Fix OK, Battenhouse H et al (2014) Outcomes and complications of intracranial pressure monitoring in acute liver failure: a retrospective cohort study. Crit Care Med 42:1157–1167

    Article  PubMed  PubMed Central  Google Scholar 

  • Kearney T, Dang C (2007) Diabetic and endocrine emergencies. Postgrad Med J 83:79–86

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kircheis G, Nilius R, Held C et al (1997) Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study. Hepatology 25:1351–1360

    Article  CAS  PubMed  Google Scholar 

  • Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Haussinger D (2002) Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 35:357–366

    Article  PubMed  Google Scholar 

  • Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN (2009) Hyperglycemic crises in adult patients with diabetes. Diabetes Care 32(7):1335–1343

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kodl CT, Seaquist ER (2008) Cognitive dysfunction and diabetes mellitus. Endocr Rev 29(4):494–511

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Krieger S, Jauß M, Jansen O, Theilmann L, Geißler M, Krieger D (1996) Neuropsychiatric profile and hyperintense lobus pallidus on T1-weighted magnetic resonance images in liver cirrhosis. Gastroenterology 111:147–155

    Article  CAS  PubMed  Google Scholar 

  • Kril JJ, Butterworth RF (1997) Diencephalic and cerebellar pathology in alcoholic and nonalcoholic patients with end-stage liver disease. Hepatology 26:837–841

    Article  CAS  PubMed  Google Scholar 

  • Levin DL (2008) Cerebral edema in diabetic ketoacidosis. Pediatr Crit Care Med 9:320–329

    Article  PubMed  Google Scholar 

  • Lockwood AH (1989) Neurological complications of renal disease. Neurol Clin 7(3):617–627

    CAS  PubMed  Google Scholar 

  • Lockwood AH (2000) „What’s in a name?“ Improving the care of cirrhotics. J Hepatol 32:859–861

    Article  CAS  PubMed  Google Scholar 

  • Marchesini G, Bianchi G, Merli Ma et al (2003) Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology 124:1792–1801

    Article  CAS  PubMed  Google Scholar 

  • Mahoney CA, Arieff AL. Uremic encephalopathies: clinical, biochemical, and experimental features. Am J Kidney Dis 1982; 2(3):324–336.

    Article  CAS  PubMed  Google Scholar 

  • Muto Y, Sato S, Watanabe A, for the Long-Term-Survival Study (LOTUS) Group et al (2005) Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 3:705–713

    Article  CAS  PubMed  Google Scholar 

  • Nyenwe EA, Kitabchi AE (2011) Evidence-based management of hyperglycemic emergencies in diabetes mellitus. Diabetes Res Clin Pract 94(3):340–351

    Article  PubMed  Google Scholar 

  • O’Grady JG, Schalm SW, Williams R (1993) Acute liver failure: redefining the syndromes. Lancet 342:273–275

    Article  PubMed  Google Scholar 

  • Ostapowicz GA, Fontana RJ, Schiodt FV et al (2002) Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 137:947–954

    Article  PubMed  Google Scholar 

  • Penin H (1967) Über den diagnostischen Wert des Hirnstrombildes bei der hepato-portalen Encephalopathie. Fortschr Neurol Psychiatr Grenzgeb 35:174–234

    CAS  PubMed  Google Scholar 

  • Plum F, Posner JB (1982) The diagnosis of stupor and coma, 3. Aufl. Davis, Philadelphia, S 1–86

    Google Scholar 

  • Poo JL, Gongora J, Sanchez-Avila F et al (2006) Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study. Ann Hepatol 5(4):281–288

    PubMed  Google Scholar 

  • Powell EE, Pender MP, Chalk JB et al (1990) Improvement in chronic hepatocerebral degeneration following liver transplantation. Gastroenterology 98:1079–1082

    Article  CAS  PubMed  Google Scholar 

  • Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R (2007) Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 45:549–559

    Article  PubMed  Google Scholar 

  • Quadri AM, Ogunwale BO, Mullen KD (2007) Can we ignore minimal hepatic encephalopathy any longer? Hepatology 45:547–548

    Article  Google Scholar 

  • Randolph C, Hilsabeck R, Kato A et al (2009) International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN). Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Int 29(5):629–635

    Article  PubMed  Google Scholar 

  • Rose C, Butterworth RF, Zayed J et al (1999) Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology 117(3):640–644

    Article  CAS  PubMed  Google Scholar 

  • Rovira A, Alonso J, Córdoba J (2008) MR imaging findings in hepatic encephalopathy. Am J Neuroradiol 29(9):1612–1621

    Article  CAS  PubMed  Google Scholar 

  • Russo G, Conte P, Sallusto L, Di Maggio A, Scatizzi A (1989) Electrophysiologic follow-up (brainstem acoustic evoked potentials and visual evoked potentials) in chronic uremic patients treated with various therapeutic protocols. Riv Neurol 59(6):229–238

    CAS  PubMed  Google Scholar 

  • Sass DA, Shakil AO (2005) Fulminant hepatic failure. Liver Transpl 11(6):594–605

    Article  PubMed  Google Scholar 

  • Savage MW, Mah PM, Weetman AP, Newell-Price J. Endocrine emergencies. Postgrad Med J 2004; 80:506–515.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schomerus H, Hamster W (2001) Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab Brain Dis 16:13–19

    Article  Google Scholar 

  • Schomerus H, Schreiegg J (1993) Prevalence of latent portasystemic encephalopathy in an unselected population of patients with liver cirrhosis in general practice. Z Gastroenterol 31:231–234

    CAS  PubMed  Google Scholar 

  • Schomerus H, Hamster W, Blunck H, Reinhard K, Mayer K, Dölle W (1981) Latent portasystemic encephalopathy: I. Nature of cerebral functional defects and their effect on fitness to drive. Dig Dis Sci 26:622–630

    Article  CAS  PubMed  Google Scholar 

  • Shalimar, Acharya SK (2015) Management in acute liver failure. J Clin Exp Hepatol 5(Suppl 1):S104–S115

    Article  CAS  PubMed  Google Scholar 

  • Souheaver GT, Ryan JR, Dewolfe AS (1982) Neuropsychological patterns in uremia. J Clin Psychol 38(3):490–496

    Article  CAS  PubMed  Google Scholar 

  • Stoner GD (2005) Hyperosmolar hyperglycemic state. Am Fam Physician 71:1723–1730

    PubMed  Google Scholar 

  • Tryc AB, Goldbecker A, Berding G, Rümke S, Afshar K, Shahrezaei GH, Pflugrad H et al (2013) Cirrhosis-related Parkinsonism: prevalence, mechanisms and response to treatments. J Hepatol 58(4):698–705

    Article  CAS  PubMed  Google Scholar 

  • Victor M, Adams RD, Cole M (1965) The acquired (non-Wilsonina) type of chronic hepatocerebral degeneration. Medicine (Baltimore) 44:345–394

    Article  CAS  Google Scholar 

  • Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, Weissenborn K, Wong P (2014) Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology 60(2):715–735

    Article  PubMed  Google Scholar 

  • Wang HC, Brown P, Lees AJ (1998) Acute movement disorders with bilateral basal ganglia lesions in uremia. Mov Disord 13(6):952–957

    Article  CAS  PubMed  Google Scholar 

  • Weissenborn K, Scholz M, Hinrichs H, Wiltfang J, Schmidt FW, Künkel H (1990) Neurophysiological assessment of early hepatic encephalopathy. Electroencephalogr Clin Neurophysiol 75:289–295

    Article  CAS  PubMed  Google Scholar 

  • Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H (2001) Neuropsychological characterization of hepatic encephalopathy. J Hepatol 34:768–773

    Article  CAS  PubMed  Google Scholar 

  • Weissenborn K, Tietge UJ, Bokemeyer M, Mohammadi B, Bode U, Manns MP, Caselitz M (2003) Liver transplantation improves hepatic myelopathy: evidence by three cases. Gastroenterology 124:346–351

    Article  PubMed  Google Scholar 

  • Weissenborn K (2015) The clinical relevance of minimal hepatic encephalopathy – a critical look. Dig Dis 33(4):555–561. doi:10.1159/000375348

    Article  PubMed  Google Scholar 

  • Windebank AJ, Feldman EL (2001) Diabetes and the nervous system. In: Aminoff MJ (Hrsg) Neurology and general medicine. Churchill Livingstone, Philadelphia, S 341–364

    Google Scholar 

  • Wolfsdorf J, Glaser N, Sperling MA (2006) Diabetic ketoacidosis in infants, children, and adolescents. A consensus statement from the American Diabetes Association. Diabetes Care 29:1150–1159

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurologische Klinik, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland

    Karin Weissenborn

Authors
  1. Karin Weissenborn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karin Weissenborn .

Editor information

Editors and Affiliations

  1. Essen, Germany

    Peter Berlit

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag GmbH Deutschland

About this entry

Cite this entry

Weissenborn, K. (2017). Metabolische Enzephalopathien. In: Berlit, P. (eds) Klinische Neurologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-44768-0_112-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-44768-0_112-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-44768-0

  • Online ISBN: 978-3-662-44768-0

  • eBook Packages: Springer Referenz Medizin

Publish with us

Policies and ethics

Search

Navigation